Kotak Institutional Equities, who is bearish on Divi’s Laboratories, said that the stock’s current valuations of 49 times its estimated price-to-earnings ratio for FY28, is already pricing in growth potential.
Kotak Institutional Equities, who is bearish on Divi’s Laboratories, said that the stock’s current valuations of 49 times its estimated price-to-earnings ratio for FY28, is already pricing in growth potential.